Log in to search using one of your social media accounts:

 

Middle East respiratory syndrome coronavirus (MERS-CoV) – Saudi Arabia

Update on MERS CoV in Saudi Arabia, 7 November 2017
Source: WHO Disease Outbreaks - Category: Infectious Diseases Tags: news Source Type: news

Related Links:

CONCLUSION: As for MERS Co-V infections, underlying comorbidities impacted the clinical outcomes of OC43 infections. PMID: 29402475 [PubMed - as supplied by publisher]
Source: Medecine et Maladies Infectieuses - Category: Infectious Diseases Tags: Med Mal Infect Source Type: research
Between 9 December 2017 and 17 January 2018, the National IHR Focal Point of The Kingdom of Saudi Arabia reported 20 additional cases of Middle East Respiratory Syndrome (MERS), including eight deaths. In addition, one death from a previously reported case was reported to WHO.
Source: WHO Disease Outbreaks - Category: Infectious Diseases Tags: news Source Type: news
Middle East respiratory syndrome coronavirus (MERS-CoV) is a zoonotic virus from camels causing significant mortality and morbidity in humans in the Arabian Peninsula. The epidemiology of the virus remains poorly understood, and while case-based and seroepidemiological studies have been employed extensively throughout the epidemic, viral sequence data have not been utilised to their full potential. Here we use existing MERS-CoV sequence data to explore its phylodynamics in two of its known major hosts, humans and camels. We employ structured coalescent models to show that long-term MERS-CoV evolution occurs exclusively in ...
Source: eLife - Category: Biomedical Science Tags: Epidemiology and Global Health Genomics and Evolutionary Biology Source Type: research
Disease News Outbreak on Middle East coronavirus (MERS-CoV) in Malaysia.
Source: WHO Disease Outbreaks - Category: Infectious Diseases Tags: news Source Type: news
Extracorporeal life support (ECLS) has been widely utilized to treat neonatal respiratory failure for two decades. However, its uptake in the case of adult respiratory failure has been slow because of a paucity of quality evidence and a sluggish tempo of ECLS-related technological advances. In recent years, interest in ECLS has been piqued after encouraging results were reported from its use during the 2009 H1N1 influenza pandemic. In a world constantly under threat from another influenza epidemic or deadly novel respiratory infection, e.g., the severe acute respiratory syndrome (SARS) virus, the Middle East respiratory sy...
Source: ASAIO Journal - Category: Medical Devices Tags: Review Article Source Type: research
Publication date: Available online 28 December 2017 Source:Antiviral Research Author(s): Min-Han Lin, David C. Moses, Chih-Hua Hsieh, Shu-Chun Cheng, Yau-Hung Chen, Chiao-Yin Sun, Chi-Yuan Chou Severe acute respiratory syndrome coronavirus (SARS-CoV) emerged in southern China in late 2002 and caused a global outbreak with a fatality rate around 10% in 2003. Ten years later, a second highly pathogenic human CoV, MERS-CoV, emerged in the Middle East and has spread to other countries in Europe, North Africa, North America and Asia. As of November 2017, MERS-CoV had infected at least 2102 people with a fatality rate of about ...
Source: Antiviral Therapy - Category: Virology Source Type: research
Abstract Severe acute respiratory syndrome coronavirus (SARS-CoV) emerged in southern China in late 2002 and caused a global outbreak with a fatality rate around 10% in 2003. Ten years later, a second highly pathogenic human CoV, MERS-CoV, emerged in the Middle East and has spread to other countries in Europe, North Africa, North America and Asia. As of November 2017, MERS-CoV had infected at least 2102 people with a fatality rate of about 35% globally, and hence there is an urgent need to identify antiviral drugs that are active against MERS-CoV. Here we show that a clinically available alcohol-aversive drug, dis...
Source: Antiviral Research - Category: Virology Authors: Tags: Antiviral Res Source Type: research
On 11 December 2017, the National IHR Focal Point of the United Arab Emirates (UAE) reported one additional case of Middle East Respiratory Syndrome (MERS-CoV) infection. Detailed information concerning the case reported, a 39-year-old male residing in Hemma Region, Oman can be found in a separate document (see link below). The case is currently asymptomatic, is in home isolation in Oman, and is being monitored for the development of symptoms. 


Source: WHO Disease Outbreaks - Category: Infectious Diseases Tags: news Source Type: news
Extracorporeal life support (ECLS) has been widely utilized to treat neonatal respiratory failure for two decades. However, its uptake in the case of adult respiratory failure has been slow because of a paucity of quality evidence and a sluggish tempo of ECLS-related technological advances. In recent years, interest in ECLS has been piqued after encouraging results were reported from its use during the 2009 H1N1 influenza pandemic. In a world constantly under threat from another influenza epidemic or deadly novel respiratory infection, e.g., the severe acute respiratory syndrome (SARS) virus, the Middle East respiratory sy...
Source: ASAIO Journal - Category: Medical Devices Tags: Review Article Source Type: research
Disease outbreak news for MERS-CoV in Saudi Arabia
Source: WHO Disease Outbreaks - Category: Infectious Diseases Tags: news Source Type: news
More News: Coronavirus | Infectious Diseases | MERS | Middle East Health | Outbreaks | Respiratory Medicine | Saudi Arabia Health